Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.16% |
| 2 | Financials | 6.59% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 4.26% |
| 5 | Consumer Discretionary | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Wabtec
WAB
$49.1B
| $10.4M | 0.01% |
108,613
+52,024
| +92% | +$4.82M |
|
|
ATCO
2077
DELISTED
Atlas Corp.
ATCO
| $10.4M | 0.01% |
711,502
-114,339
| -14% | -$1.69M |
|
2078
Alnylam Pharmaceuticals
ALNY
$27.5B
| $10.4M | 0.01% |
63,957
-19,460
| -23% | -$2.96M |
|
|
GXII
2079
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
| $10.4M | 0.01% |
1,069,608
| – | – |
|
|
IEA
2080
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $10.4M | 0.01% |
880,722
-211,155
| -19% | -$2.26M |
|
|
BWIN
2081
Baldwin Insurance Group
BWIN
$2.69B
| $10.4M | 0.01% |
388,921
+266,373
| +217% | +$7.67M |
|
2082
LeMaitre Vascular
LMAT
$2.32B
| $10.4M | 0.01% |
224,492
+63,548
| +39% | +$2.84M |
|
|
NOGN
2083
DELISTED
Nogin, Inc. Common Stock
NOGN
| $10.4M | 0.01% |
52,193
+21,867
| +72% | +$4.34M |
|
|
ACRO
2084
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
| $10.4M | 0.01% |
1,072,176
| – | – |
|
2085
Precigen
PGEN
$2.24B
| $10.4M | 0.01% |
4,933,435
+2,849,987
| +137% | +$6.94M |
|
|
BPMC
2086
DELISTED
Blueprint Medicines
BPMC
| $10.4M | 0.01% |
162,778
+130,844
| +410% | +$9.39M |
|
2087
Blue Owl Capital
OWL
$6.96B
| $10.4M | 0.01% |
819,134
+769,078
| +1,536% | +$9.74M |
|
|
FTEV
2088
DELISTED
FinTech Evolution Acquisition Group
FTEV
| $10.4M | 0.01% |
1,058,809
+30,546
| +3% | +$297K |
|
|
AGGR
2089
DELISTED
Agile Growth Corp
AGGR
| $10.4M | 0.01% |
1,060,719
-18,385
| -2% | -$179K |
|
|
DISCK
2090
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $10.4M | 0.01% |
414,630
+189,727
| +84% | +$5.15M |
|
|
CSII
2091
DELISTED
Cardiovascular Systems, Inc.
CSII
| $10.3M | 0.01% |
457,405
-137,290
| -23% | -$2.66M |
|
2092
ABM Industries
ABM
$2.81B
| $10.3M | 0.01% |
224,221
+138,802
| +162% | +$6.04M |
|
2093
CXApp
CXAI
$13.4M
| $10.3M | 0.01% |
1,024,806
+298,063
| +41% | +$2.98M |
|
2094
Energy Recovery
ERII
$446M
| $10.3M | 0.01% |
+510,959
| New | +$9.95M |
|
|
WE
2095
DELISTED
WeWork Inc.
WE
| $10.3M | 0.01% |
37,682
+23,608
| +168% | +$6.76M |
|
|
CHCT
2096
Community Healthcare Trust
CHCT
$523M
| $10.3M | 0.01% |
243,453
+107,412
| +79% | +$4.65M |
|
2097
Mercer International
MERC
$42.3M
| $10.3M | 0.01% |
734,962
+97,883
| +15% | +$1.26M |
|
|
MODV
2098
DELISTED
ModivCare
MODV
| $10.3M | 0.01% |
88,859
+27,118
| +44% | +$3.13M |
|
|
CSTA
2099
DELISTED
Constellation Acquisition Corp I
CSTA
| $10.2M | 0.01% |
1,044,418
-398,080
| -28% | -$3.89M |
|
2100
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $10.2M | 0.01% |
+1,797,079
| New | +$11M |
|
Similar funds
Millennium Management's Q1 2022 Portfolio in Review
As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Millennium Management's Q1 2022 filing shows 1,492 new, 2,451 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
- Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.